Groupe FH Ortho Competitors and Similar CompaniesClear all

Groupe FH Ortho's competitors and similar companies include Trilliant Surgical, Midmark, Nipponflex and Penumbra.

	Groupe FH Ortho Groupe FH Ortho manufactures medical devices.	Trilliant Surgical Trilliant Surgical is a company that creates and manufactures medical devices for small bone orthopedic correction.	Midmark Midmark is a company that manufactures and supplies medical, dental, and veterinary equipment.	Nipponflex Nipponflex is a company that specializes in the development of the scientific sleeping system.	Penumbra Penumbra is a healthcare company that designs, develops, and manufactures medical devices.
Founding Date	Founding Date 1964	Founding Date 2007	Founding Date 1915	Founding Date 1987	Founding Date 2004
Type	Type Private	Type Subsidiary	Type Private	Type Private	Type Public
Tags	Tags Healthcare medical devices	Tags Manufacturing & Industrial medical devices medtech surgical solutions	Tags Healthcare dental ecommerce medical devices veterinary	Tags Healthcare medical devices	Tags Healthcare medical devices
Locations	Locations HQ	Locations Houston, US HQ	Locations Versailles, US HQ Brisbane City, AU Melbourne, AU Perth, AU Sydney, AU Bruxelles, BE São Paulo, BR see more	Locations Maringá, BR HQ Aracaju, BR Brasilia, BR Cabedelo, BR Campo Grande, BR Contagem, BR Cuiabá, BR see more	Locations Alameda, US HQ Darlinghurst, AU São Paulo, BR Berlin, DE Berlin, DE Rivoli, IT Alameda, US see more
Employees	Employees 1091% increase	Employees 224% decrease	Employees 2,200	Employees 1,586	Employees 4,2008% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $717m (FY, 2022)	Revenue (est.) N/A	Revenue (est.) $1.4b (FY, 2025)
Operating ⚠
Product Categories	Product Categories N/A	Product Categories N/A	Product Categories 27 (Apr, 2024)	Product Categories N/A	Product Categories 7 (Dec, 2023)
Trademarks (US)	Trademarks (US) N/A	Trademarks (US) N/A	Trademarks (US) 73 (Apr, 2024)	Trademarks (US) N/A	Trademarks (US) 43 (Dec, 2023)